CAD
ARLZ

Craig A. Drill’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Craig A. Drill’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$4.65M Buy
958,945
+374,345
+64% +$1.71M 19.07% 2
2016
Q2 		$1.93M Buy
584,600
+245,300
+72% +$926K 3.8% 6
2016
Q1 		$1.21M Buy
+339,300
New +$1.75M 3.04% 8

Other funds holding ARLZ

PCM
PAR Capital Management Boston, Massachusetts $4.03B AUM 35.05% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
TLCM
Tiger Legatus Capital Management New York $62.4M AUM 24.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
VOAM
Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Craig A. Drill's ARLZ Position: Q3 2016 in Review

Craig A. Drill increased its Aralez Pharmaceuticals Inc. (ARLZ) stake by 64% in Q3 2016, buying an estimated $1.71M and bringing the position to 958,945 shares worth $4.65M. The position accounts for 19.07% of the portfolio, ranked #2.

Craig A. Drill first reported a position in ARLZ in Q1 2016 and has held it in 3 quarters since. 83 funds tracked by Wall St. Rank hold ARLZ as of Q3 2016.

  • Craig A. Drill held 958,945 shares of Aralez Pharmaceuticals Inc. worth $4.65M as of Q3 2016.
  • Craig A. Drill bought 374,345 Aralez Pharmaceuticals Inc. shares in Q3 2016, an estimated $1.71M.
  • Aralez Pharmaceuticals Inc. made up 19.07% of Craig A. Drill's portfolio in Q3 2016, its #2 holding.
  • Craig A. Drill first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and has held it in 3 quarters since.
  • 83 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2016.

Based on Craig A. Drill's 13F filing for Q3 2016, filed 10 Nov 2016.